— Know what they know.
Not Investment Advice
Also trades as: SHIEF (OTC) · $vol 0M

STX.L LSE

Shield Therapeutics plc
1W: +14.4% 1M: +7.2% 3M: -2.5% YTD: -44.6% 1Y: -26.5% 3Y: -43.3% 5Y: -86.5%
£6.00 ($0.08)
-0.05 (-0.83%)
 
Weekly Expected Move ±12.0%
£5 £5 £6 £7 £7
LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 63 · £63.6M mcap · 409M float · 0.590% daily turnover

📊 Key Metrics

TTM
£91M
Revenue
+302.1% YoY
£-27M
Net Income
+60.4% YoY
£-20M
Free Cash Flow
+55.3% YoY
58.1%
Gross Margin
0.7%
Op. Margin
-7.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE321.4%
ROA-59.0%
ROIC2603.7%

Valuation

P/E-8.0
P/B-4.9
EV/EBITDA0.0

Leverage

Debt/Equity-1.46
Current Ratio0.75
Interest Cov.-1.4x

Quality Scores

Piotroski F4/9
Altman Z—
Beneish M-1.59

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms